Rockefeller Financial Services’s Concert Pharmaceuticals, Inc. CNCE Stock Holding History

Rockefeller Financial Services’s Portfolio CNCE Stock Details CNCE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q4	–	Sell	-9,533	Closed	-$141K	–	540
2017 Q3	$141K	Sell	9,533 -756	-7%	-$11K	﹤0.01%	364
2017 Q2	$144K	Hold	10,289	–	–	﹤0.01%	319
2017 Q1	$176K	Buy	10,289 +1,689	+20%	+$20.3K	﹤0.01%	319
2016 Q4	$88K	Hold	8,600	–	–	﹤0.01%	384
2016 Q3	$87K	Hold	8,600	–	–	﹤0.01%	362
2016 Q2	$97K	Hold	8,600	–	–	﹤0.01%	359
2016 Q1	$117K	Hold	8,600	–	–	﹤0.01%	362
2015 Q4	$163K	Hold	8,600	–	–	﹤0.01%	352
2015 Q3	$161K	Hold	8,600	–	–	﹤0.01%	350
2015 Q2	$128K	Buy	8,600 +3,939	+85%	+$60K	﹤0.01%	345
2015 Q1	$71K	Buy	+4,661	New	+$65K	﹤0.01%	398

Other funds holding CNCE

BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

ISL

Ingalls & Snyder LLC New York $2.83B AUM 21.61% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

LCM

Laurion Capital Management New York $2.29B AUM 75.73% 1-Year Est. Return

GPP

Great Point Partners Greenwich, Connecticut $435M AUM 318.81% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return

Rockefeller Financial Services's CNCE Position: Q4 2017 in Review

Rockefeller Financial Services sold out of Concert Pharmaceuticals, Inc. (CNCE) in Q4 2017, closing a stake of 9,533 shares — an estimated $141K sold.

Rockefeller Financial Services first reported a position in CNCE in Q1 2015 and held it in 11 quarters. The position peaked at $176K in Q1 2017. 114 funds tracked by Wall St. Rank hold CNCE as of Q4 2017.

Rockefeller Financial Services reported no remaining Concert Pharmaceuticals, Inc. position as of Q4 2017 after selling out during the quarter.
Rockefeller Financial Services sold 9,533 Concert Pharmaceuticals, Inc. shares in Q4 2017, an estimated $141K.
Rockefeller Financial Services first reported a position in Concert Pharmaceuticals, Inc. in Q1 2015 and held it in 11 quarters.
Rockefeller Financial Services's Concert Pharmaceuticals, Inc. position peaked at $176K in Q1 2017.
114 funds tracked by Wall St. Rank held Concert Pharmaceuticals, Inc. as of Q4 2017.

Based on Rockefeller Financial Services's 13F filing for Q4 2017, filed 2 Feb 2018.